ArticleScientific reports2019

Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.

Fat-Moon Suk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.